Exscientia Plc ( EXAI) - Key Metrics
Stock symbol EXAI is outdated, potentially delisted? Maybe it is available on other exchange?
EXAI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.03 | -$0.29 | -$0.29 | -$0.29 |
| 2024Q1 | $0.04 | -$0.17 | -$0.24 | -$0.27 |
| 2023Q4 | $0.02 | -$0.33 | $0.01 | -$0.02 |
| 2023Q3 | $0.07 | -$0.25 | -$0.27 | -$0.31 |
| 2023Q2 | $0.02 | -$0.29 | -$0.33 | -$0.39 |
EXAI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -3.55 |
| 2024Q1 | ? | -6.49 |
| 2023Q4 | ? | -3.84 |
| 2023Q3 | ? | -3.69 |
| 2023Q2 | ? | -4.01 |
EXAI
Price: $4.84
52 week price:
Earnings Per Share: -1.52 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 445040
Market Capitalization: 733.9 million